Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.

Ítems similars

• INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL
  per: Allan, N, et al.
  Publicat: (1994)
• A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
  per: Le Bon, A, et al.
  Publicat: (2006)
• Intracellular production of IFN-alpha 2b in Lactococcus lactis
  per: Bayat, Omid, et al.
  Publicat: (2014)
• Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
  per: Sara Moqbil, et al.
  Publicat: (2022-11-01)
• Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN)
  per: Nelson Ranieri Tirone, et al.
  Publicat: (2021-11-01)